Renaissance of Medicine
TECHNOLOGY
Renaissance of Medicine
Selective RNAi Technology
MediciBIO develops gene therapy for incurable genetic diseases through systemic infrastructure - genetic disease analysis, RNAi screening, efficacy evaluation, CMC study, and collaboration of clinical advisors.
Analysis of Genetic Diseases
MediciBIO primarily defines driver mutations of genetic diseases through genetic analysis.
RNAi Screening
MediciBIO screens and optimizes siRNA or ASOs (anti-sense oligonucleotides) for selection of candidates that discriminate mutant mRNAs over the corresponding wild-type mRNAs.
In vitro/in vivo Evaluation
Establishment of in vitro/in vivo genetic models via constitutive expression or gene-editing enables preclinical evaluation and prediction of clinical efficacy.
CMC for Gene Therapy Products
Experience in CMC study and IND filing of highly complex genetic drugs including oligonucleotides facilitates rapid clinical entry and drug development.
MediciBIO develops gene therapy for incurable genetic diseases through systemic infrastructure-genetic disease analysis, RNAi screening, efficacy evaluation, CMC study, and collaboration of clinical advisors.
Analysis of Genetic Diseases
MediciBIO primarily defines driver mutations of genetic diseases through genetic analysis.
RNAi Screening
MediciBIO screens and optimizes siRNA or ASOs (anti-sense oligonucleotides) for selection of candidates that discriminate mutant mRNAs over the corresponding wild-type mRNAs.
In vitro/in vivo Evaluation
Establishment of in vitro/in vivo genetic models via constitutive expression or gene-editing enables preclinical evaluation and prediction of clinical efficacy.
CMC for Gene Therapy Products
Experience in CMC study and IND filing of highly complex genetic drugs including oligonucleotides facilitates rapid clinical entry and drug development.
Addressㅣ A-2207, 184, Jungbu-daero, Giheung-gu, Yongin-si,
Gyeonggi-do, 17095 Republic of Korea
Telㅣ +82-31-895-6707 Faxㅣ +82-70-8676-6706
Copyright © MediciBIO Co.,LTD. All rights reserved.
Headquarter A-2207, 184, Jungbu-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 17095 Republic of Korea
Branch Office A-13, 3rd Floor, 194-25, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28160 Republic of Korea
Tel ㅣ +82-31-895-6707 Fax ㅣ +82-70-8676-6706 Email ㅣ biz@medicibio.com
Copyright © MediciBIO Co.,LTD. All rights reserved.